PapersFlow Research Brief
Advanced Drug Delivery Systems
Research Guide
What is Advanced Drug Delivery Systems?
Advanced Drug Delivery Systems are engineered platforms, such as nanoparticles, polymeric carriers, and hydrogels, designed to enhance drug bioavailability, control release kinetics, and enable targeted delivery to specific tissues including mucosal, ocular, and nasal routes.
The field encompasses 43,203 works focused on chitosan-based nanoparticles, polymeric microspheres, mucoadhesive formulations, and protein delivery via mucosal paths. Key materials include PLGA, which offers biocompatibility, biodegradability, and tunable erosion times for controlled release (Makadia and Siegel, 2011). Lipidic nanocarriers demonstrate that particle size and polydispersity index directly influence clinical efficacy and bioavailability of poorly soluble drugs (Danaei et al., 2018).
Topic Hierarchy
Research Sub-Topics
Chitosan-Based Nanoparticles for Mucosal Drug Delivery
This sub-topic examines the synthesis, characterization, and mucoadhesive properties of chitosan nanoparticles for delivering drugs across mucosal barriers. Researchers investigate particle size optimization, surface modifications, and controlled release profiles to enhance bioavailability.
Polymeric Microspheres in Advanced Drug Delivery
Focuses on the design and fabrication of biodegradable polymeric microspheres, such as PLGA-based systems, for sustained drug release. Studies explore encapsulation efficiency, degradation kinetics, and in vivo performance in targeted applications.
Mucoadhesive Formulations for Ocular Delivery
This area covers development of mucoadhesive gels, nanoparticles, and inserts to prolong residence time and enhance penetration in ocular tissues. Research evaluates bioadhesion strength, corneal toxicity, and therapeutic outcomes for anterior and posterior eye conditions.
Nasal Drug Delivery Systems for Proteins and Peptides
Investigates nasal formulations using permeation enhancers and nanoparticles to facilitate transport of large biomolecules across the nasal epithelium. Researchers study absorption mechanisms, immunogenicity, and efficacy for vaccines and hormones.
Stimuli-Responsive Nanocarriers for Mucosal Routes
Explores pH-, temperature-, and enzyme-responsive nanoparticles and hydrogels tailored for mucosal environments. Studies focus on triggered release mechanisms, biocompatibility, and targeted applications in inflamed tissues.
Why It Matters
Advanced Drug Delivery Systems address limitations of conventional drugs by improving solubility, stability, and site-specific delivery, with lipid- or polymer-based nanoparticles enhancing pharmacological properties for parenteral administration (Allen and Cullis, 2004). PLGA carriers enable controlled release over wide erosion times, supporting applications in drug delivery and tissue engineering (Makadia and Siegel, 2011). PEGylation extends nanoparticle circulation time, improving delivery of drugs and genes, as shown in formulations that reduce clearance and enhance mucosal penetration (Suk et al., 2015). These systems have overcome early clinical hurdles, enabling mainstream use in therapeutics (Allen and Cullis, 2004).
Reading Guide
Where to Start
"Engineering precision nanoparticles for drug delivery" by Mitchell et al. (2020) introduces core principles of nanoparticle design for targeted delivery, serving as an accessible entry with 6743 citations.
Key Papers Explained
"Engineering precision nanoparticles for drug delivery" (Mitchell et al., 2020) establishes design principles, which "Stimuli-responsive nanocarriers for drug delivery" (Mura et al., 2013) builds upon by adding trigger-based release. "Nano based drug delivery systems: recent developments and future prospects" (Patra et al., 2018) expands to chitosan and polymeric applications, while "Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier" (Makadia and Siegel, 2011) details material-specific mechanics. "Drug Delivery Systems: Entering the Mainstream" (Allen and Cullis, 2004) contextualizes clinical viability.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current work emphasizes mucoadhesive chitosan nanoparticles for nasal and ocular protein delivery, with focus on biodegradation and immune modulation, as reflected in the 43,203 papers without recent preprints specifying new shifts.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Engineering precision nanoparticles for drug delivery | 2020 | Nature Reviews Drug Di... | 6.7K | ✓ |
| 2 | Nano based drug delivery systems: recent developments and futu... | 2018 | Journal of Nanobiotech... | 6.2K | ✓ |
| 3 | Stimuli-responsive nanocarriers for drug delivery | 2013 | Nature Materials | 5.9K | ✕ |
| 4 | A review of chitin and chitosan applications | 2000 | Reactive and Functiona... | 5.9K | ✕ |
| 5 | Drug Delivery Systems: Entering the Mainstream | 2004 | Science | 4.5K | ✕ |
| 6 | Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlle... | 2011 | Polymers | 4.4K | ✓ |
| 7 | Designing hydrogels for controlled drug delivery | 2016 | Nature Reviews Materials | 4.2K | ✓ |
| 8 | Impact of Particle Size and Polydispersity Index on the Clinic... | 2018 | Pharmaceutics | 4.1K | ✓ |
| 9 | PEGylation as a strategy for improving nanoparticle-based drug... | 2015 | Advanced Drug Delivery... | 4.0K | ✓ |
| 10 | Environment-sensitive hydrogels for drug delivery | 2001 | Advanced Drug Delivery... | 3.8K | ✕ |
Frequently Asked Questions
What are the main components of nano-based drug delivery systems?
Nano-based systems include chitosan nanoparticles, polymeric microspheres, and lipidic carriers that incorporate lipophilic and hydrophilic drugs. They protect molecules from degradation and enhance bioavailability (Patra et al., 2018). Chitosan provides mucoadhesive properties for ocular and nasal delivery (Ravi Kumar, 2000).
How does PLGA function in controlled drug delivery?
PLGA is a biocompatible, biodegradable polymer with tunable mechanical properties and erosion times for fabricating drug delivery devices. It supports sustained release of peptides and proteins via mucosal routes (Makadia and Siegel, 2011).
What role does particle size play in lipidic nanocarriers?
Particle size and polydispersity index determine the clinical applications of lipidic nanocarriers by affecting bioavailability and stability of poorly soluble drugs. Smaller sizes improve tissue penetration and reduce clearance (Danaei et al., 2018).
Why is PEGylation used in nanoparticle delivery?
PEGylation modifies nanoparticle surfaces to prolong blood circulation and evade immune clearance. It enhances mucosal drug and gene delivery efficiency (Suk et al., 2015).
What are stimuli-responsive nanocarriers?
Stimuli-responsive nanocarriers release drugs in response to environmental triggers like pH or temperature. They enable precise control over delivery to targeted tissues (Mura et al., 2013).
How do hydrogels contribute to drug delivery?
Hydrogels provide controlled drug release through their tunable structure and responsiveness to stimuli. Environment-sensitive variants adjust release based on local conditions (Li and Mooney, 2016; Qiu and Park, 2001).
Open Research Questions
- ? How can precision engineering of nanoparticles optimize mucosal penetration for protein therapeutics?
- ? What polydispersity thresholds maximize clinical translation of lipidic nanocarriers?
- ? Which stimuli-responsive mechanisms best balance biodegradability and controlled release in chitosan systems?
- ? How does PEGylation density affect immune responses in ocular drug delivery?
- ? What erosion profiles of PLGA best suit long-term nasal peptide delivery?
Recent Trends
The field maintains 43,203 works with sustained emphasis on chitosan nanoparticles and PLGA carriers for mucosal delivery, as no new preprints or news alter trajectories from established papers like Patra et al. on nano systems and Danaei et al. (2018) on particle size impacts.
2018Research Advanced Drug Delivery Systems with AI
PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Advanced Drug Delivery Systems with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers